Investment Objective
Emkay Capital Builder AIF is an open-ended Multi-cap Category 3 AIF, that aims to identify companies with the potential to build wealth over an investment horizon of 3-5+ years.
The fund considers top 600 companies (by market cap) as its universe and is guided by a well-defined portfolio construction discipline to filter stocks based on strict limits and a three-pronged investment process.
Three-Pronged Investment Process
Earnings Growth
E-Qual Risk Framework
Purchase Price Discipline
Investment Framework
Long Term Investing
- Low churn
- Be patient before & after investing
Conviction & Patience
- Focus on absolute Returns and high emphasis on Purchase Price.
Compounding is the Name of the Game
- Winning sustainable wealth.
Do your own Homework
- Research backed & process oriented investments.
Focused Portfolio
- Allocation Discipline to avoid concentration risk.
Avoid Mistakes
- Avoid unscrupulous promoters/ management
- Businesses getting irrelevant
- Highly leveraged companies
- Euphoric valuation
Investment Theme
Using a bottom-up stock-picking strategy, the Capital Builder AIF aims to consistently identify businesses offering robust growth prospects and intrinsic value at a reasonable price. We employ in-house tools like E-Qual (India’s first governance-dedicated stock-picking model) to mitigate risks related to management quality.
Sector Allocation
Emkay Capital Builder uses a multi-cap strategy with 20-25 stocks.
*As on 31st March 2022
The underlying portfolio strategy for the Capital builder AIF has been a consistent performing with zero blowouts since its inception. This can largely be attributed to the intensive processes laid out in the E-Qual Risk module that make it nearly impossible for any evasive business to make its way into the fund.
| TOP 5 HOLDINGS | PERCENTAGE |
|---|---|
| ZOMATO LTD | 12.9% |
| DIVI S LABORATORIES LTD | 12.8% |
| ICICI BANK LTD | 9.9% |
| HDFC BANK LTD | 9.4% |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 8.3% |
Performance Update (Emkay Capital Builder PMS)
*As on 31st March 2022
| Name | Value |
|---|---|
| Emkay Capital Builder TWRR | 17.60 |
| BSE 500 (TRI) | 16.10 |
| Outperformance (TWRR v/s Benchmark) | 1.50 |
Note: The portfolio returns are TWRR returns.
*As on 31st March 2022
Fund Management Team
Manish Sonthalia
Director and Chief Investment Officer, Emkay Investment Managers Ltd.
Manish Sonthalia serves as the Chief Investment Officer of Emkay Investment Managers Ltd. He has over 3 decades of exhaustive experience in equity fund management and research covering Indian Markets.
A commerce graduate from St. Xavier’s College, Kolkata, Manish is also a member of The Institute of Cost and Works Accountants of India, The Institute of Chartered Accountants of India and The Institute of Company Secretaries of India. He has completed his MBA in Finance from IISWBM. His research paper on Indian Markets ‘A Rising Consumer Class’, was published by the Global World Economic Forum in 2010. His views are frequently sought by leading Media channels in India as well as globally.
Kashyap Javeri
Head of Research and Fund Manager, Emkay Investment Managers Ltd.
Kashyap Javeri is a Fund Manager with more than a decade of experience in company and sector research. He brings exceptional insights into stocks and economy. Prior to joining Emkay Investment Managers, he was a rated BFSI analyst in Emkay Institutional Equities for eight years, and also worked with Sharekhan Ltd. as a midcap analyst. Kashyap brings with him immense in-depth knowledge not only in a variety of manufacturing and services sectors, but also in banking and economics.
Get the Emkay Capital Builder Presentation On Your Mail
Get the Emkay Capital Builder Presentation On Your Mail
SEBI Registration Details
| Entity Name | Type/ Nature of business Activity | SEBI Registration No. | Fund Managers |
|---|---|---|---|
| Emkay Emerging Stars Trust | SEBI Registered CAT III Alternative Investment Fund | IN/AIF3/24-25/1499 |
|
